Diabetes-Independent Retinal Phenotypes in an Aldose Reductase Transgenic Mouse Model
Aldose reductase (AR), the first and rate-limiting enzyme of the polyol pathway, has been implicated in the onset and development of the ocular complications of diabetes, including cataracts and retinopathy. Despite decades of research conducted to address possible mechanisms, questions still persis...
Main Authors: | Jonathan Mark Petrash, Biehuoy Shieh, David A. Ammar, Michelle G. Pedler, David J. Orlicky |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Metabolites |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-1989/11/7/450 |
Similar Items
-
Nanogel-Facilitated In-Situ Delivery of a Cataract Inhibitor
by: Dixa Gautam, et al.
Published: (2021-08-01) -
Ocular Hypertension Results in Hypoxia within Glia and Neurons throughout the Visual Projection
by: Assraa Hassan Jassim, et al.
Published: (2022-04-01) -
In Search of Differential Inhibitors of Aldose Reductase
by: Francesco Balestri, et al.
Published: (2022-03-01) -
The use of dimethylsulfoxide as a solvent in enzyme inhibition studies: the case of aldose reductase
by: Livia Misuri, et al.
Published: (2017-01-01) -
Research progress on the roles of aldose reductase in diabetic retinopathy
by: Hong-Zhe Li, et al.
Published: (2015-07-01)